Dehydroepiandrosterone (DHEA) response to i.v. ACTH in patients with chronic fatigue syndrome

Hormone and Metabolic Research

Volumn 31, Issue 1, 1999, Pages 18-21

  De Becker, Pascale ^a,b   De Meirleir, K ^a,b   Joos, E ^a   Campine, I ^a,b   Van Steenberge, E ^a,b   Smitz, J ^a   Velkeniers, B ^a  

^a FACULTY OF MEDICINE AND PHARMACY   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

ACTH; Chronic Fatigue Syndrome; DHEA; Hypothalamo Pituitary Adrenal Axis

Indexed keywords

CORTICOTROPIN; PRASTERONE; TETRACOSACTIDE;

ADRENAL GLAND; ADULT; ARTICLE; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN TEST; HORMONAL REGULATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0033059384     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-978690     Document Type: Article

References (30)

1. Holmes GP, Kaplan JE, Gantz NM, Komaroff AL, Schonberger LB, Straus SE, Jones JF, Dubois RE, Cunningham-Rundles C, Pahwa S, Tosato G, Zegans LS, Purtilo DT, Brown N, Schooley RT, Brus I. Chronic fatigue syndrome: A working case definition. Ann Intern Med 1988; 108: 387-9
2. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff AL. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med 1994; 121: 953-9
3. Wilson A, Hickie I, Lloyd A, Hadzi-Pavlovic D, Boughton C, Dwyer J, Wakefield D. Longitudinal study of outcome of chronic fatigue syndrome. Brit Med J 1994; 308: 756-9
4. Dinan T. Neuroendocrinology of chronic fatigue syndrome. J Chron Fat Synd 1996; 2: 69-70
5. Demitrack MA, Dale JK, Straus SE, Laue L, Listwak SJ, Kruesi MJ, Chrousus GP, Gold PW. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab 1991; 73: 1224-34
6. Bearn J, Allain T, Coskeran P, Munro N, Butler J, McGregor A, Wessely S. Neuroendocrine reponses to d-fenfluramine and insulin-induced hypoglycemia in chronic fatigue syndrome. Biol Psychiatry 1995; 37: 245-52
7. Griep EN, Boersma JW, De Kloet ER. Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome. J Rheumatol 1993; 20: 469
8. Cleare A, Bearn J, Allain T, McGregor A, Wessely S, Murray S, O'Keane V. Contrasting neuroendocrine responses in depression and chronic fatigue syndrome. J Affective Disord 1995; 34: 283-9
9. Poteliakhoff A. Adrenocortical activity and some clinical findings in acute and chronic fatigue. J Psychosom Res 1981; 25: 91-5
10. Demitrack MA. Neuroendocrine aspects of chronic fatigue syndrome: implications for diagnosis and research. In: Straus S (editor). Chronic Fatigue Syndrome. New York: Marcel Dekker inc., 1994: 285-308
11. Wessely S. The neuropsychiatry of chronic fatigue syndrome. Lancet 1996; 347: 858
12. Gold PW, Goodwin FK, Chrousus GP. Clinical and biochemical manifestations of depression. Relationship to the neurobiology of stress (part 1 of 2). New Engl J Med 1988; 319: 348-53
13. Suhadolnik RJ, Peterson DL, O'Brien K, Cheney PR, Herst CV, Reichenbach NL, Kon N, Horvath SE, lacono KT, Adelson ME, De Meirleir K, De Becker P, Charubala R, Pfleiderer W. Biochemical evidence for a novel low molecular weight 2-5A dependent RNaseL in chronic fatigue syndrome. Journal of interferon and Cytokine Research 1997; 17: 377-85
14. Jacobson MA, Fusaro RE, Galmarini M, Lang W. Decreased serum dehydroepiandrosterone is associated with an increased progression of human immunodeficiency virus infection in men with CD4 cell counts of 200-499. J Infect Dis 1991; 164: 864-8
15. Rook GA, Zumla A. Gulf War Syndrome: is it due to a systemic shift in cytokine balance towards a Th 2 profile? Lancet 1997; 349: 1831-3
16. Bakheit AM, Behan PO, Dinan TG, Gray CE, O'Keane V. Possible upregulation of hypothalamic 5-hydroxytryptamine receptors in patients with the postviral fatigue syndrome. Brit Med J 1992; 304: 1010-2
17. Majeed T, Dinan TG, Thakore J, Gray C, Behan PO. Defective dexamethasone induced growth hormone release in chronic fatigue syndrome: evidence for glucocorticoid receptor resistance and lack of plasticity? J Irish Colleges of Physicians and Surgeons 1995; 24: 20-4
18. Buchwald D, Cheney PR, Peterson DL, Henry B, Wormsley SB, Geiger A, Ablashi DV, Salahuddin SZ, Saxinger C, Biddle R, Kikinis R, Jolesz FA, Folks T, Balachandran N, Peter JB, Gallo RC, Komaroff AL. A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpesvirus type 6 infection. Ann Intern Med 1992; 116: 103-13
19. Buchwald D, Wener M, Pearlmank T, Kith P. Markers of inflammation and immune activation in chronic fatigue and chronic fatigue syndrome. Journal of Rheumatol 1997; 24: 372-6
20. Mowbray J. Evidence of chronic enterovirus infections in M.E. The Clinical and Scientific Basis of M.E., 1991: 304-9
21. Yousef G, Mann G, Smith D. Chronic enterovirus infection in patients with Postviral Fatigue Syndrome. Lancet 1988; i: 146-50
22. Gow JW, Behan WM, Simpson K, McGarry F, Keir S, Behan PO. Studies on enterovirus in patients with chronic fatigue syndrome. Clin Infect Dis 1994; 18 (suppl 1): S126-9
23. DeFreitas E, Hilliard B, Cheney P, Bell DS, Kiggundu E, Sankey D, Wroblewska Z, Palladino JP, Woodward JP, Koprowski H. Retro-viral sequences related to human T-lymphotropic virus type II in patients with chronic fatigue immune dysfunction syndrome. Proc Natl Acad Scie USA 1991; 88: 2922-6
24. Levy JA. Viral studies of chronic fatigue syndrome. Clin Infect Dis 1994; 18 (suppl 1): S117-20
25. Southern P, Oldstone MB. Medical consequences of persistent-viral infection. New Engl J Med 1986; 314: 359-67
26. Henderson E, Yang JY, Schwartz A. Dehydroepiandrosterone (DHEA) and synthetic DHEA analogs are modest inhibitors of HIV-I III B replication AIDS. Res Hum Revtroviruses 1992; 8: 625-31
27. Daynes RA, Araneo BA, Hennebold J, Eniontina J, Mu HH. Steroids as regulators of the mammalian immune response. J Invest Dermatol 1995; 105: 14S-9S
28. Himmel P, Brown S, Coppolino R. A pilot study employing dehydroepiandrosterone (DHEA) in the treatment of the chronic fatigue syndrome. Proceedings of American Association for Chronic Fatigue Syndrome. Research Conference, San Francisco, Oct 1996: p 92
29. Salvato P, Thompson C. An open study of DHEA (dehydroepiandrosterone) in chronic fatigue syndrome. Proceedings of American Association for Chronic Fatigue Syndrome. Research Conference, San Francisco, Oct 1996: p 98
30. Baxter JD, Tyrell JB. The adrenal cortex. In: Felig P, Baxter JD, Broadus, AE, Frohman LA (eds). Endocrinology and metabolism. New York: McGraw-Hill, 1981: 385-510